Low-T3 syndrome
Showing 1 - 25 of >10,000
Rectal Cancer, Surgery, Patient Activation Trial in Canada, United States (Patient Activation Booklet and nursing support for
Recruiting
- Rectal Cancer
- +4 more
- Patient Activation Booklet and nursing support for patients with LARS
-
Boston, Massachusetts
- +5 more
Aug 17, 2022
Patient Empowerment, Low Anterior Resection Syndrome, Colo-rectal Cancer Trial in Canada (Interactive online informational and
Recruiting
- Patient Empowerment
- +6 more
- Interactive online informational and peer support app
-
Vancouver, British Columbia, Canada
- +4 more
Aug 17, 2022
Premature Infant, Respiratory Distress Syndrome in Premature Infant, Neurodevelopmental Outcome Trial in Calgary, Edmonton,
Recruiting
- Premature Infant
- +2 more
- 30% oxygen group
- 60% oxygen group
-
Calgary, Alberta, Canada
- +5 more
Oct 4, 2022
Low Anterior Resection Syndrome, Rectal Cancer Trial in Montreal, Montréal (Transanal Irrigation)
Recruiting
- Low Anterior Resection Syndrome
- Rectal Cancer
- Transanal Irrigation
-
Montreal, Quebec, Canada
- +1 more
Jan 18, 2022
Facet Syndrome of Lumbar Spine Trial in Canada (Neurolyser XR)
Recruiting
- Facet Syndrome of Lumbar Spine
- Neurolyser XR
-
Vancouver, British Columbia, Canada
- +4 more
Aug 16, 2021
Stellate Ganglion, Radiofrequency Ablation, Complex Regional Pain Syndromes Trial in Cairo (Radiofrequency stellate ganglion
Not yet recruiting
- Stellate Ganglion
- +3 more
- Radiofrequency stellate ganglion block using ultrasound guidance (SGB)
- +2 more
-
Cairo, EgyptNational Cancer Institute
Sep 5, 2023
Rectal Cancer, Low Anterior Resection Syndrome Trial in Montréal (Survivorship Care Initiative)
Not yet recruiting
- Rectal Cancer
- Low Anterior Resection Syndrome
- Survivorship Care Initiative
-
Montréal, Quebec, CanadaJewish General Hospital
Jul 14, 2021
Followed by Surgery For MRI-defined T3 Mid-low Rectal Cancer
Completed
- Rectal Cancer
- total mesorectal excision
- (no location specified)
Aug 9, 2022
LARS - Low Anterior Resection Syndrome Trial in Seoul (Ramosetron)
Not yet recruiting
- LARS - Low Anterior Resection Syndrome
-
Seoul, Jongro-gu, Korea, Republic ofSeoul National University Hospital
Dec 13, 2022
Covid19, SARS-CoV Infection, ARDS Trial in Minneapolis (Instilled T3, Placebo Therapy)
Recruiting
- Covid19
- +3 more
- Instilled T3
- Placebo Therapy
-
Minneapolis, MinnesotaUniversity of Minnesota
Sep 1, 2022
Clonal Cytopenia of Undetermined Significance, Essential Thrombocythemia, Myelodysplastic Syndrome Trial in Los Angeles
Not yet recruiting
- Clonal Cytopenia of Undetermined Significance
- +4 more
- Biospecimen Collection
- +6 more
-
Los Angeles, California
- +1 more
Oct 4, 2023
IBS - Irritable Bowel Syndrome Trial (Module 1, Module 2, Module 3)
Not yet recruiting
- IBS - Irritable Bowel Syndrome
- Module 1
- +4 more
- (no location specified)
Oct 31, 2023
Non-thyroidal Illness Syndrome
Active, not recruiting
- Euthyroid Sick Syndromes
- +3 more
-
Bochum, NRW, Germany
- +5 more
Nov 17, 2020
Analgesia Trial in Cairo (Thermal Radiofrequency, Chemical Neurolysis)
Recruiting
- Analgesia
- Thermal Radiofrequency
- Chemical Neurolysis
-
Cairo, EgyptWalaa Y Elsabeeny
Apr 4, 2022
Post-Viral Fatigue Syndrome Trial in Vancouver (Low-Dose Naltrexone, Placebo)
Not yet recruiting
- Post-Viral Fatigue Syndrome
- Low-Dose Naltrexone
- Placebo
-
Vancouver, British Columbia, CanadaBC Women's Hospital + Health Centre
Jun 17, 2022
Heart Failure With Preserved Ejection Fraction, Low Triiodothyronine Syndrome Trial in Philadelphia (liothyronine or )
Recruiting
- Heart Failure With Preserved Ejection Fraction
- Low Triiodothyronine Syndrome
- liothyronine or placebo
-
Philadelphia, PennsylvaniaPenn Medicine
Dec 21, 2021
Diabetes, Type 1 Trial (Antithymocyte Globulin, Placebo (for ATG))
Recruiting
- Diabetes Mellitus, Type 1
- Antithymocyte Globulin
- Placebo (for ATG)
-
Gainesville, FloridaUniversity of Florida
Jan 5, 2023
Breast Cancer Trial (Trastuzumab Deruxtecan)
Not yet recruiting
- Breast Cancer
- Trastuzumab Deruxtecan
- (no location specified)
Jul 10, 2023
MDS, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic Trial in Newcastle (Subcutaneous azacitidine, Oral
Not yet recruiting
- Myelodysplastic Syndromes
- +3 more
- Subcutaneous azacitidine
- Oral decitabine/cedazuridine
-
Newcastle, New South Wales, AustraliaCalvary Mater Newcastle
May 29, 2023
Depth of Sedation and Its Impact on Cerebrovascular Reactivity
Not yet recruiting
- ARDS, Human
- Masimo O3 NIRS cerebral oximetry and SedLine processed EEG
-
Winnipeg, Manitoba, CanadaUniversity of Manitoba
Apr 27, 2023
Low Vision in Children Trial in Toronto (Biofeedback Training, Sham - simulated BT)
Recruiting
- Low Vision in Children
- Biofeedback Training
- Sham - simulated BT
-
Toronto, Ontario, CanadaCNIB
Mar 29, 2022
Hunter Syndrome Trial in Canada, France (Idursulfase-IT, Elaprase)
Not yet recruiting
- Hunter Syndrome
-
Calgary, Alberta, Canada
- +3 more
Sep 4, 2023
Acute Myeloid Leukemia in Remission, Chronic Myelomonocytic Leukemia, Minimal Residual Disease Trial in Seattle (procedure,
Active, not recruiting
- Acute Myeloid Leukemia in Remission
- +5 more
- Allogeneic Bone Marrow Transplantation
- +5 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
May 13, 2021
The Cognitive-Prefrail Syndrome and Its Association With Adverse
Active, not recruiting
- Cognitive-prefrailty
- +2 more
- Data Collection
-
Montréal, Quebec, CanadaJewish General Hospital
Aug 11, 2022
Wire in Shouldice Surgery to Keep Recurrence Rate Low After One
Recruiting
- Inguinal Hernia
- suture material
-
Thornhill, Ontario, CanadaShouldice Hospital
May 18, 2023